Amgen (United States)

American biotechnology company headquartered in Thousand Oaks, California, founded in 1980 as Applied Molecular Genetics and one of the largest independent biotechnology companies in the world. Develops, manufactures and markets biologic and small molecule medicines in oncology, haematology, inflammation, bone health, cardiovascular disease, nephrology and rare disease, including epoetin alfa, filgrastim, denosumab, etanercept, evolocumab and a large biosimilars portfolio, with manufacturing sites in the United States, Puerto Rico, Ireland, the Netherlands and Singapore.